Particulars |
|
|
|
Company Name
| Aurobindo Pharma Ltd
| Year End
| 202303
|
Full Year |
Equity (₹ Cr.) |
58.59 |
B.V. (₹) |
318.50 |
Sales(₹ Cr.) |
12,792.28 |
NP (₹ Cr.) |
1,220.43 |
NP Var (%) |
-21.00 |
Div% |
750.00 |
CPS(₹) |
28.30 |
EPS (₹) |
20.80 |
Traded Value(₹ Lakhs) |
1,055.61 |
52 Week High |
1,177.00 |
52 Week Low |
582.00 |
Price BSE |
1,131.00 |
Price NSE |
1,131.00 |
Market Capital (₹ Cr.) |
66,278.45 |
P/C Ratio |
40.00 |
P/E Ratio |
54.30 |
Price Vs.BV |
3.55 |
|
Latest Quarter |
Year End |
202312 |
Sales (₹ Cr.) |
2,663.87 |
NP(₹ Cr.) |
623.78 |
NP Var % |
93.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
11,197.53 |
OPM |
10.11 |
NP |
1,400.90 |
NP Var (%) |
30.76 |
EPS |
33.56 |
PE |
33.71 |
|
|